None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Duration of 6 months or longer 2) Numeric Rating Scale (NRS) for current neck area pain of 5 or higher 3) Patients who have agreed to voluntarily participate in the clinical trial and given written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients diagnosed with serious pathology(s) which may cause neck pain (e.g. malignant tumor, spinal infection, inflammatory spondylitis) 2) Progressive neurologic deficit or severe neurologic symptoms 3) Pathologies of non-spinal or soft tissue origin or high severity which may cause neck or radiating arm pain (e.g. malignant tumor, spinal infection, inflammatory spondylitis, fibromyalgia, rheumatic arthritis, gout) 4) Other chronic diseases which may interfere with treatment effect or interpretation of results (e.g. cardiovascular disorder, renal disease, diabetic neuropathy, dementia, epilepsy) 5) Current intake of steroids, immunosuppressant medicine, psychiatric medicine or other medication which may interfere with treatment results 6) Patients considered unsuitable or unsafe to receive acupuncture (e.g. patients with hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, severe diabetes with high risk of infection, severe cardiovascular diseases) 7) Patients who were treated with invasive interventions such as acupuncture or injections, or with medicine that may potentially influence pain such as NSAIDs (nonsteroidal antiinflammatory drugs) within the past week 8) History of cervical surgery within the past 3 months 9) Pregnancy or plans of pregnancy 10) Severe psychopathy 11) Participation in other clinical studies 12) Inability to give written informed consent 13) Other reasons rendering trial participation inappropriate as judged by the researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference between visual analogue scale (VAS) of neck pain for the past 3 days between 5 weeks post-baseline and baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference between visual analogue scale (VAS) of radiating arm pain for the past 3 days at each timepoint and baseline, respectively ;Difference between Neck Disability Index (NDI) at each timepoint and baseline, respectively;Adverse events;Credibility and Expectancy Questionnaire ;Difference between the EuroQol Visual Analogue Scale (EQ-VAS) at each timepoint and baseline, respectively;Difference between Northwick Park Neck Pain Questionnaire (NPQ) at each timepoint and baseline, respectively;Patient Global Impression of Change (PGIC) ;Physical examination;Economic evaluation (time-related costs) ;Drug Consumption ;Difference between the Short Form Health Survey 12 (SF-12) at each timepoint and baseline, respectively ;Difference between the 5 level version of EuroQol-5 Dimension (EQ-5D-5L) at each timepoint and baseline, respectively ;Economic evaluation (medical costs);Economic evaluation (lost productivity costs) ;Difference between numeric rating scale (NRS) of radiating arm pain for the past 3 days at each timepoint and baseline, respectively ;Difference between numeric rating scale (NRS) of neck pain for the past 3 days at each timepoint and baseline, respectively | — |
Countries
Korea, Republic of
Contacts
Jaseng Medical Foundation